Abstract

Reactive oxygen species (ROS) accumulation is a cardinal feature of skeletal muscle atrophy. ROS refers to a collection of radical molecules whose cellular signals are vast, and it is unclear which downstream consequences of ROS are responsible for the loss of muscle mass and strength. Here we show that lipid hydroperoxides (LOOH) are increased with age and disuse, and the accumulation of LOOH by deletion of glutathione peroxidase 4 (GPx4) is sufficient to augment muscle atrophy. LOOH promoted atrophy in a lysosomal-dependent, proteasomal-independent manner. In young and old mice, genetic and pharmacologic neutralization of LOOH or their secondary reactive lipid aldehydes robustly prevented muscle atrophy and weakness, indicating that LOOH-derived carbonyl stress mediates age- and disuse-induced muscle dysfunction. Our findings provide novel insights for the role of LOOH in sarcopenia including a therapeutic implication by pharmacologic suppression.

Data availability

All data generated or analyzed during this study are included in the manuscript.

Article and author information

Author details

  1. Hiroaki Eshima

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  2. Justin L Shahtout

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  3. Piyarat Siripoksup

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  4. MacKenzie J Pearson

    Sciex, Framingham, United States
    Competing interests
    MacKenzie J Pearson, is affiliated with Sciex. The author has no financial interests to declare..
  5. Ziad S Mahmassani

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  6. Patrick J Ferrara

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  7. Alexis W Lyons

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  8. John Alan Maschek

    Metabolomics Core Research Facility, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  9. Alek D Peterlin

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2837-7446
  10. Anthony RP Verkerke

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  11. Jordan M Johnson

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  12. Anahy Salcedo

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  13. Jonathan J Petrocelli

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  14. Edwin R Miranda

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  15. Ethan J Anderson

    Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, United States
    Competing interests
    No competing interests declared.
  16. Sihem Boudina

    Department of Nutrition and Integrative Physiology, College of Health,, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  17. Qitao Ran

    Department of Cell Systems and Anatomy, The University of Texas Health Science Center at San Antonio, San Antonio, United States
    Competing interests
    No competing interests declared.
  18. James E Cox

    Department of Biochemistry, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  19. Micah J Drummond

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    Competing interests
    No competing interests declared.
  20. Katsuhiko Funai

    Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, United States
    For correspondence
    kfunai@utah.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3802-4756

Funding

National Institutes of Health (DK107397)

  • Katsuhiko Funai

National Institutes of Health (HL149870)

  • Sihem Boudina

National Institutes of Health (HL139451)

  • Ziad S Mahmassani

National Institutes of Health (DK130555)

  • Alek D Peterlin

National Institutes of Health (AG073493)

  • Jonathan J Petrocelli

American Heart Association (915674)

  • Piyarat Siripoksup

American Heart Association (18PRE33960491)

  • Anthony RP Verkerke

American Heart Association (19PRE34380991)

  • Jordan M Johnson

Larry H. & Gail Miller Family Foundation (Predoctoral fellowship)

  • Patrick J Ferrara

Uehara Memorial Foundation (Postdoctoral fellowship)

  • Hiroaki Eshima

National Institutes of Health (DK127979)

  • Katsuhiko Funai

National Institutes of Health (GM144613)

  • Katsuhiko Funai

National Institutes of Health (AG074535)

  • Katsuhiko Funai

National Institutes of Health (AG063077)

  • Katsuhiko Funai

National Institutes of Health (AG050781)

  • Micah J Drummond

National Institutes of Health (HL122863)

  • Ethan J Anderson

National Institutes of Health (AG057006)

  • Ethan J Anderson

National Institutes of Health (AG064078)

  • Qitao Ran

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#20-07007) of the University of Utah.

Human subjects: Informed consent and consent to publish was obtained from subjects. All procedures were approved by institutional IRB at the University of Utah and conformed to the Declaration of Helsinki and Title 45, US Code of Federal Regulations, Part 46, "Protection of Human Subjects."

Copyright

© 2023, Eshima et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,340
    views
  • 402
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hiroaki Eshima
  2. Justin L Shahtout
  3. Piyarat Siripoksup
  4. MacKenzie J Pearson
  5. Ziad S Mahmassani
  6. Patrick J Ferrara
  7. Alexis W Lyons
  8. John Alan Maschek
  9. Alek D Peterlin
  10. Anthony RP Verkerke
  11. Jordan M Johnson
  12. Anahy Salcedo
  13. Jonathan J Petrocelli
  14. Edwin R Miranda
  15. Ethan J Anderson
  16. Sihem Boudina
  17. Qitao Ran
  18. James E Cox
  19. Micah J Drummond
  20. Katsuhiko Funai
(2023)
Lipid hydroperoxides promote sarcopenia through carbonyl stress
eLife 12:e85289.
https://doi.org/10.7554/eLife.85289

Share this article

https://doi.org/10.7554/eLife.85289

Further reading

    1. Cell Biology
    2. Computational and Systems Biology
    Sarah De Beuckeleer, Tim Van De Looverbosch ... Winnok H De Vos
    Research Article

    Induced pluripotent stem cell (iPSC) technology is revolutionizing cell biology. However, the variability between individual iPSC lines and the lack of efficient technology to comprehensively characterize iPSC-derived cell types hinder its adoption in routine preclinical screening settings. To facilitate the validation of iPSC-derived cell culture composition, we have implemented an imaging assay based on cell painting and convolutional neural networks to recognize cell types in dense and mixed cultures with high fidelity. We have benchmarked our approach using pure and mixed cultures of neuroblastoma and astrocytoma cell lines and attained a classification accuracy above 96%. Through iterative data erosion, we found that inputs containing the nuclear region of interest and its close environment, allow achieving equally high classification accuracy as inputs containing the whole cell for semi-confluent cultures and preserved prediction accuracy even in very dense cultures. We then applied this regionally restricted cell profiling approach to evaluate the differentiation status of iPSC-derived neural cultures, by determining the ratio of postmitotic neurons and neural progenitors. We found that the cell-based prediction significantly outperformed an approach in which the population-level time in culture was used as a classification criterion (96% vs 86%, respectively). In mixed iPSC-derived neuronal cultures, microglia could be unequivocally discriminated from neurons, regardless of their reactivity state, and a tiered strategy allowed for further distinguishing activated from non-activated cell states, albeit with lower accuracy. Thus, morphological single-cell profiling provides a means to quantify cell composition in complex mixed neural cultures and holds promise for use in the quality control of iPSC-derived cell culture models.

    1. Cell Biology
    Joan Chang, Adam Pickard ... Karl E Kadler
    Research Article

    Collagen-I fibrillogenesis is crucial to health and development, where dysregulation is a hallmark of fibroproliferative diseases. Here, we show that collagen-I fibril assembly required a functional endocytic system that recycles collagen-I to assemble new fibrils. Endogenous collagen production was not required for fibrillogenesis if exogenous collagen was available, but the circadian-regulated vacuolar protein sorting (VPS) 33b and collagen-binding integrin α11 subunit were crucial to fibrillogenesis. Cells lacking VPS33B secrete soluble collagen-I protomers but were deficient in fibril formation, thus secretion and assembly are separately controlled. Overexpression of VPS33B led to loss of fibril rhythmicity and overabundance of fibrils, which was mediated through integrin α11β1. Endocytic recycling of collagen-I was enhanced in human fibroblasts isolated from idiopathic pulmonary fibrosis, where VPS33B and integrin α11 subunit were overexpressed at the fibrogenic front; this correlation between VPS33B, integrin α11 subunit, and abnormal collagen deposition was also observed in samples from patients with chronic skin wounds. In conclusion, our study showed that circadian-regulated endocytic recycling is central to homeostatic assembly of collagen fibrils and is disrupted in diseases.